Proteasome

proteasome
proteasomes protein complexes inside eukaryotes archaea
bacteria
eukaryotes
located nucleus cytoplasm
main function proteasome degrade unneeded damaged proteins proteolysis
chemical reaction breaks peptide bonds
enzymes carry reactions called proteases
proteasomes part major mechanism cells regulate concentration proteins degrade misfolded proteins
degradation process yields peptides amino acids long
degraded shorter amino acid sequences synthesizing proteins
proteins tagged degradation small protein called ubiquitin
tagging reaction catalyzed enzymes called ubiquitin ligases
protein tagged single ubiquitin molecule
signal ligases attach additional ubiquitin molecules
result polyubiquitin chain bound proteasome
allowing degrade tagged protein
structure
proteasome cylindrical complex
core
stacked rings central pore
ring composed individual proteins
rings made subunits protease active sites
sites located interior surface rings
target protein enter central pore degraded
outer rings subunits function maintain
gate
proteins enter barrel
subunits controlled binding
cap
structures regulatory particles recognize polyubiquitin tags attached protein substrates initiate degradation process
system ubiquitination proteasomal degradation ubiquitin proteasome system
proteasomal degradation pathway essential cellular processes
including cell cycle
regulation gene expression
responses oxidative stress
importance proteolytic degradation inside cells role ubiquitin proteolytic pathways acknowledged award nobel prize chemistry aaron ciechanover
avram hershko irwin rose
discovery ubiquitin proteasome system
protein degradation cells thought rely lysosomes
membrane bound organelles acidic protease filled interiors degrade recycle exogenous proteins aged damaged organelles
work alfred goldberg atp dependent protein degradation reticulocytes
lack lysosomes
suggested presence intracellular degradation mechanism
shown composed distinct protein chains
novelty proteases time
work modification histones led identification unexpected covalent modification histone protein bond lysine side chain histone terminal glycine residue ubiquitin
protein function
discovered previously identified protein proteolytic degradation
atp dependent proteolysis factor
apf
protein ubiquitin
proteolytic activities system isolated multi protein complex originally called multi catalytic proteinase complex sherwin wilk marion orlowski
atp dependent proteolytic complex responsible ubiquitin dependent protein degradation discovered called proteasome
early work leading discovery ubiquitin proteasome system occurred late early technion laboratory avram hershko
aaron ciechanover worked graduate student
hershko year long sabbatical laboratory irwin rose fox chase cancer center provided key conceptual insights
rose downplayed role discovery
shared nobel prize chemistry work discovering system
electron microscopy data revealing stacked ring structure proteasome mid
structure proteasome core particle solved ray crystallography
structure solved core particle complex common form regulatory cap
proteasome subcomponents referred svedberg sedimentation coefficient
denoted
proteasome exclusively mammals cytosolic proteasome
kilodaltons
kda
molecular mass protein subunit regulatory cap subunits
core hollow enclosed cavity proteins degraded
openings ends core target protein enter
end core particle associates regulatory subunit multiple atpase active sites ubiquitin binding sites
structure recognizes polyubiquitinated proteins transfers catalytic core
alternative form regulatory subunit called particle associate core essentially manner particle
play role degradation foreign peptides produced infection virus
number diversity subunits contained core particle depends organism
number distinct specialized subunits larger multicellular unicellular organisms larger eukaryotes prokaryotes
particles consist stacked heptameric ring structures composed types subunits
subunits structural nature
subunits predominantly catalytic
outer rings stack consist subunits
serve docking domains regulatory particles alpha subunits termini form gate blocks unregulated access substrates interior cavity
rings consist subunits protease active sites perform proteolysis reactions
distinct catalytic activities identified purified complex
chymotrypsin
trypsin peptidylglutamyl peptide hydrolyzing
size proteasome conserved angstroms
interior chamber wide
entrance narrow
suggesting substrate proteins partially unfolded enter
archaea thermoplasma acidophilum
subunits identical
eukaryotic proteasomes yeast distinct types subunit
mammals
subunits catalytic
share common mechanism
distinct substrate specificities considered chymotrypsin
trypsin
peptidyl glutamyl peptide hydrolyzing
phgh
alternative forms denoted
expressed hematopoietic cells response exposure pro inflammatory signals cytokines
interferon gamma
proteasome assembled alternative subunits immunoproteasome
substrate specificity altered relative normal proteasome
particle eukaryotes consists individual proteins divisible subassemblies
protein base binds directly ring core particle
protein lid polyubiquitin bound
ten base proteins atpase subunits aaa family
evolutionary homolog atpases exists archaea
called pan
proteasome activating nucleotidase
association particles requires binding atp atpase subunits
atp hydrolysis required assembled complex degrade folded ubiquitinated proteins
note step substrate unfolding requires energy atp hydrolysis
atp binding support steps required protein degradation
complex assembly
gate opening
translocation
proteolysis
fact
atp binding atpases supports rapid degradation unfolded proteins
atp hydrolysis required unfolding
clear energy coupling steps
atomic structure proteasome solved
massive efforts
understood
general
associates regulates core particle
fact
particles bind sites rings core particle
induce gate opening mechanism
early proteasome reconstituted yeast
saccharomyces cerevisiae
core particle recombinantly expressed
coli yeast lid
regulatory particle
structure determined subnanometer resolution single particle electron microscopy
regulatory particle responsible stimulating degrade proteins
primary function regulatory atpases open gate blocks entry substrates degradation chamber
mechanism proteasomal atpase open gate recently elucidated
gate opening
substrate degradation
requires termini proteasomal atpases
specific motif
hbyx motif
atpases termini bind pockets top
tether atpase complex proteolytic complex
joining substrate unfolding equipment degradation machinery
binding termini pockets stimulates opening gate
key lock
opens door
precise mechanism
key lock
mechanism functions structurally elucidated
proteasomes associate type regulatory particle
regulatory particle
heptameric structure atpases promote degradation short peptides complete proteins
presumed complex unfold larger substrates
structure reg
mechanisms binds core particle terminal tails subunits induces ring conformational open gate suggest similar mechanism particle
expression particle induced interferon gamma responsible
conjunction immunoproteasome subunits
generation peptides bind major histocompatibility complex
assembly proteasome complex process due number subunits associate form active complex
subunits synthesized terminal
propeptides
post translationally modified assembly particle expose proteolytic active site
particle assembled half proteasomes
consists membered pro ring attached membered ring
association rings half proteasomes triggers threonine dependent autolysis propeptides expose active site
interactions mediated salt bridges hydrophobic interactions conserved alpha helices disruption mutation damages proteasome ability assemble
assembly half proteasomes
turn
initiated assembly subunits heptameric ring
forming template association pro ring
assembly subunits characterized
general
assembly maturation regulatory particles
believed assemble distinct subcomponents
atpase base ubiquitin recognizing lid
atpases base assemble pairwise manner mediated coiled coil interactions
order nineteen subunits regulatory particle bound regulatory mechanism prevents exposure active site assembly complete
proteins targeted degradation proteasome covalent modification lysine residue requires coordinated reactions enzymes
step
ubiquitin activating enzyme
hydrolyzes atp adenylylates ubiquitin molecule
transferred active site cysteine residue concert adenylylation ubiquitin
adenylylated ubiquitin transferred cysteine enzyme
ubiquitin conjugating enzyme
step
member highly diverse class enzymes ubiquitin ligases
recognizes specific protein ubiquitinated catalyzes transfer ubiquitin target protein
target protein labeled ubiquitin monomers
form polyubiquitin chain
recognized proteasome lid
confers substrate specificity system
number
proteins expressed depends organism cell type
enzymes present humans
indicating huge number targets ubiquitin proteasome system
mechanism polyubiquitinated protein targeted proteasome fully understood
ubiquitin receptor proteins terminal ubiquitin
ubl
domain ubiquitin
uba
domains
ubl domains recognized proteasome caps uba domains bind ubiquitin helix bundles
receptor proteins escort polyubiquitinated proteins proteasome
specifics interaction regulation unclear
ubiquitin protein amino acids long named due ubiquitous nature
highly conserved sequence found eukaryotic organisms
genes encoding ubiquitin eukaryotes arranged tandem repeats
possibly due heavy transcription demands genes produce ubiquitin cell
proposed ubiquitin slowest evolving protein identified date
ubiquitin lysine residues ubiquitin ligated
resulting types polyubiquitin chains
chains additional ubiquitin linked lysine previous ubiquitin role proteasome targeting
types chains involved processes
protein ubiquitinated
recognized regulatory particle atp dependent binding step
substrate protein enter interior particle contact proteolytic active sites
particle central channel narrow gated terminal tails ring subunits
substrates partially unfolded enter core
passage unfolded substrate core called translocation necessarily occurs deubiquitination
order substrates deubiquitinated unfolded clear
processes rate limiting step proteolysis reaction depends specific substrate
proteins
unfolding process rate limiting
deubiquitination slowest step proteins
extent substrates unfolded translocation
substantial tertiary structure
nonlocal interactions disulfide bonds
sufficient inhibit degradation
gate formed subunits prevents peptides longer residues entering interior particle
atp molecules bound initial recognition step hydrolyzed translocation
energy needed substrate unfolding
required translocation
assembled proteasome degrade unfolded proteins presence hydrolyzable atp analog
degrade folded proteins
indicating energy atp hydrolysis substrate unfolding
passage unfolded substrate opened gate occurs facilitated diffusion cap atp bound state
mechanism unfolding globular proteins necessarily general
dependent amino acid sequence
long sequences alternating glycine alanine shown inhibit substrate unfolding decreasing efficiency proteasomal degradation
results release partially degraded byproducts
possibly due decoupling atp hydrolysis unfolding steps
glycine alanine repeats found nature
silk fibroin
epstein barr virus gene products bearing sequence stall proteasome
helping virus propagate preventing antigen presentation major histocompatibility complex
mechanism proteolysis subunits core particle threonine dependent nucleophilic attack
mechanism depend water molecule deprotonation reactive threonine hydroxyl
degradation occurs central chamber formed association rings release partially degraded products
reducing substrate short polypeptides typically residues long
range residues depending organism substrate
biochemical mechanism determines product length fully characterized
catalytic subunits common mechanism
slightly substrate specificities
considered chymotrypsin
trypsin
peptidyl glutamyl peptide hydrolyzing
phgh
variations specificity result interatomic contacts local residues active sites subunit
catalytic subunit possesses conserved lysine residue required proteolysis
proteasome produces short peptide fragments
cases products biologically active functional molecules
transcription factors regulating expression specific genes
including component mammalian complex
synthesized inactive precursors ubiquitination subsequent proteasomal degradation converts active form
activity requires proteasome cleave substrate protein internally
processively degrading terminus
suggested long loops proteins surfaces serve proteasomal substrates enter central cavity
majority protein remains
similar effects observed yeast proteins
mechanism selective degradation regulated ubiquitin
proteasome dependent processing
rup
proteasomal substrates ubiquitinated degraded
exceptions general rule
proteasome plays normal role post translational processing protein
proteasomal activation processing internal proteolysis major
proteins hypothesized unstable due intrinsically unstructured regions
degraded ubiquitin independent manner
ubiquitin independent proteasome substrate enzyme ornithine decarboxylase
ubiquitin independent mechanisms targeting key cell cycle regulators reported
subject ubiquitin dependent degradation
finally
structurally abnormal
misfolded
highly oxidized proteins subject ubiquitin independent independent degradation conditions cellular stress
proteasome ubiquitous essential eukaryotes
prokaryotes
including archaea bacterial order actinomycetales share homologs proteasome
bacteria possess heat shock genes hslv hslu
gene products multimeric protease arranged layered ring atpase
hslv protein hypothesized resemble ancestor proteasome
general
hslv essential bacteria
bacteria possess
protists possess hslv systems
sequence analysis suggests catalytic subunits diverged earlier evolution predominantly structural subunits
bacteria express proteasome
subunits high sequence identity archaeal eukaryotic subunits
sequence identity lower
presence proteasomes bacteria result lateral gene transfer
diversification subunits eukaryotes ascribed multiple gene duplication events
cell cycle progression controlled ordered action cyclin dependent kinases
cdks
activated specific cyclins demarcate phases cell cycle
mitotic cyclins
persist cell minutes
shortest life spans intracellular proteins
cdk cyclin complex performed function
cyclin polyubiquitinated destroyed proteasome
directionality cell cycle
exit mitosis requires proteasome dependent dissociation regulatory component cyclin mitosis promoting factor complex
vertebrate cells
slippage
mitotic checkpoint leading premature phase exit occur delay exit spindle checkpoint
earlier cell cycle checkpoints post restriction point check phase phase similarly involve proteasomal degradation cyclin
ubiquitination promoted anaphase promoting complex
apc
ubiquitin ligase
apc
box protein complex
scf complex
key regulators cyclin degradation checkpoint control
scf regulated apc ubiquitination adaptor protein
prevents scf activity transition
individual components particle regulatory roles
gankyrin
recently identified oncoprotein
subcomponents tightly binds cyclin dependent kinase plays key role recognizing ubiquitinated
affinity ubiquitin ligase
gankyrin anti apoptotic shown overexpressed tumor cell types hepatocellular carcinoma
plants
signaling auxins
phytohormones order direction tropism plant growth
induces targeting class transcription factor repressors aux
iaa proteins proteasomal degradation
proteins ubiquitinated
scf complex auxin receptor
degradation aux
iaa proteins derepresses transcription factors auxin response factor
arf
family induces arf directed gene expression
cellular consequences arf activation depend plant type developmental stage
involved directing growth roots leaf veins
specific response arf derepression thought mediated specificity pairing individual arf aux
iaa proteins
internal external signals lead induction apoptosis
programmed cell death
resulting deconstruction cellular components primarily carried specialized proteases caspases
proteasome plays important diverse roles apoptotic process
involvement proteasome process increase protein ubiquitination
enzymes observed advance apoptosis
apoptosis
proteasomes localized nucleus observed translocate outer membrane blebs characteristic apoptosis
proteasome inhibition effects apoptosis induction cell types
general
proteasome required apoptosis
inhibiting pro apoptotic cell types studied
apoptosis mediated disrupting regulated degradation pro growth cell cycle proteins
cell lines
primary cultures quiescent differentiated cells thymocytes neurons prevented undergoing apoptosis exposure proteasome inhibitors
mechanism effect clear
hypothesized specific cells quiescent states
result differential activity pro apoptotic kinase jnk
ability proteasome inhibitors induce apoptosis rapidly dividing cells exploited recently developed chemotherapy agents bortezomib salinosporamide
response cellular stresses infection
heat shock
oxidative damage heat shock proteins identify misfolded unfolded proteins target proteasomal degradation expressed
proteins implicated increasing activity ubiquitin proteasome system
direct participants process
hand
binds exposed hydrophobic patches surface misfolded proteins recruits ubiquitin ligases chip tag proteins proteasomal degradation
chip protein
carboxyl terminus interacting protein
regulated inhibition interactions enzyme chip binding partner
similar mechanisms exist promote degradation oxidatively damaged proteins proteasome system
proteasomes localized nucleus regulated parp actively degrade inappropriately oxidized histones
oxidized proteins
form large amorphous aggregates cell
degraded directly core particle regulatory cap require atp hydrolysis tagging ubiquitin
high levels oxidative damage increases degree cross linking protein fragments
rendering aggregates resistant proteolysis
larger numbers sizes highly oxidized aggregates aging
dysregulation ubiquitin proteasome system contribute neural diseases
lead brain tumors astrocytomas
late onset neurodegenerative diseases share aggregation misfolded proteins common feature
parkinson disease alzheimer disease
large insoluble aggregates misfolded proteins form result neurotoxicity
mechanisms understood
decreased proteasome activity suggested aggregation lewy body formation parkinson
hypothesis supported observation yeast models parkinson susceptible toxicity synuclein
major protein component lewy bodies
conditions low proteasome activity
impaired proteasomal activity underlie cognitive disorders autism spectrum disorders
muscle nerve diseases inclusion body myopathy
proteasome plays straightforward critical role function adaptive immune system
peptide antigens displayed major histocompatibility complex class
mhc
proteins surface antigen presenting cells
peptides products proteasomal degradation proteins originated invading pathogen
constitutively expressed proteasomes participate process
specialized complex composed proteins
expression induced interferon gamma
primary producers peptides optimal size composition mhc binding
proteins expression increases immune response include regulatory particle
main biological role regulating production mhc ligands
specialized subunits called
altered substrate specificity
complex formed specialized subunits immunoproteasome
variant subunit
expressed thymus
leading thymus specific
thymoproteasome
function unclear
strength mhc class ligand binding dependent composition ligand terminus
peptides bind hydrogen bonding close contacts region called
pocket
mhc surface
mhc class alleles prefer hydrophobic terminal residues
immunoproteasome complex generate hydrophobic termini
due role generating activated form
anti apoptotic pro inflammatory regulator cytokine expression
proteasomal activity linked inflammatory autoimmune diseases
increased levels proteasome activity correlate disease activity implicated autoimmune diseases including systemic lupus erythematosus rheumatoid arthritis
proteasome involved intracellular antibody mediated proteolysis antibody bound virions
neutralisation pathway
protein tripartite motif family
binds immunoglobulin direct virion proteasome degraded
proteasome inhibitors effective anti tumor activity cell culture
inducing apoptosis disrupting regulated degradation pro growth cell cycle proteins
approach selectively inducing apoptosis tumor cells proven effective animal models human trials
bortezomib
molecule developed millennium pharmaceuticals marketed velcade
proteasome inhibitor reach clinical chemotherapy agent
bortezomib treatment multiple myeloma
notably
multiple myeloma observed result increased proteasome levels blood serum decrease normal levels response successful chemotherapy
studies animals bortezomib clinically significant effects pancreatic cancer
preclinical early clinical studies started examine bortezomib effectiveness treating cell related cancers
types hodgkin lymphoma
molecule ritonavir
marketed norvir
developed protease inhibitor target hiv infection
shown inhibit proteasomes free proteases
specific
chymotrypsin activity proteasome inhibited ritonavir
trypsin activity enhanced
studies animal models suggest ritonavir inhibitory effects growth glioma cells
proteasome inhibitors shown promise treating autoimmune diseases animal models
studies mice bearing human skin grafts found reduction size lesions psoriasis treatment proteasome inhibitor
inhibitors show positive effects rodent models asthma
labeling inhibition proteasome interest laboratory settings vitro vivo study proteasomal activity cells
commonly laboratory inhibitors lactacystin
natural product synthesized streptomyces bacteria
peptide
fluorescent inhibitors developed specifically label active sites assembled proteasome
